Conivaptan (CI-1025, YM087), a combined vasopressin V1A/V2 antagonist, reduces pulmonary capillary wedge pressure independent of baseline serum Na or vasopressin levels in heart failure

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Smith, WB; Russell, S; Ghali, JK; Painchaud, CA; Ghazzi, MM; Konstam, MA; Udelson, JE; Selaru, P

Published Date

  • September 1, 2001

Published In

Volume / Issue

  • 22 /

Start / End Page

  • 541 - 541

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0195-668X